▶ 調査レポート

世界の進行性再発性多発性硬化症治療市場2019
• 英文タイトル：Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の進行性再発性多発性硬化症治療市場2019 / Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Report 2019 / QYR9N3775資料のイメージです。• レポートコード：QYR9N3775
• 出版社/出版日：QYResearch / 2019年6月13日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥592,000 (USD4,000)▷ お問い合わせ
  Enterprise License￥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、進行性再発性多発性硬化症治療の世界市場について調査・分析し、進行性再発性多発性硬化症治療のメーカー別販売量、市場シェア分析、種類別販売分析（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別販売分析（診療所、Hopital、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・進行性再発性多発性硬化症治療市場概要
・進行性再発性多発性硬化症治療のメーカー別販売量・メーカー別シェア
・進行性再発性多発性硬化症治療の種類別販売量（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）
・進行性再発性多発性硬化症治療の用途別販売量（診療所、Hopital、その他）
・進行性再発性多発性硬化症治療の地域別販売量・市場シェア
・進行性再発性多発性硬化症治療の米国市場規模（2014年-2019年）
・進行性再発性多発性硬化症治療のヨーロッパ市場規模（2014年-2019年）
・進行性再発性多発性硬化症治療の中国市場規模（2014年-2019年）
・進行性再発性多発性硬化症治療の日本市場規模（2014年-2019年）
・進行性再発性多発性硬化症治療の東南アジア市場規模（2014年-2019年）
・進行性再発性多発性硬化症治療のインド市場規模（2014年-2019年）
・進行性再発性多発性硬化症治療メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・進行性再発性多発性硬化症治療のコスト分析
・進行性再発性多発性硬化症治療販売チャネル、流通業者、顧客
・進行性再発性多発性硬化症治療の世界市場動向・機会・成長要因・課題
・進行性再発性多発性硬化症治療の種類別世界市場予測（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）
・進行性再発性多発性硬化症治療の用途別世界市場予測（診療所、Hopital、その他）
・進行性再発性多発性硬化症治療の米国市場予測（2019年-2025年）
・進行性再発性多発性硬化症治療のヨーロッパ市場予測（2019年-2025年）
・進行性再発性多発性硬化症治療の中国市場予測（2019年-2025年）
・進行性再発性多発性硬化症治療の日本市場予測（2019年-2025年）
・進行性再発性多発性硬化症治療の東南アジア市場予測（2019年-2025年）
・進行性再発性多発性硬化症治療のインド市場予測（2019年-2025年）
...

The global Progressive Relapsing Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Progressive Relapsing Multiple Sclerosis Treatment market status and forecast, categorizes the global Progressive Relapsing Multiple Sclerosis Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Cognosci Inc
Genzyme Corp
MedImmune LLC
VivaCell Biotechnology Espana SL
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
COG-133
GZ-402668
Inebilizumab
VCE-0032
Others

Segment by Application
Clinic
Hopital
Others

レポート目次

Table of Contents

Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Report 2019
1 Progressive Relapsing Multiple Sclerosis Treatment Market Overview
1.1 Progressive Relapsing Multiple Sclerosis TreatmentProduct Overview
1.2 Progressive Relapsing Multiple Sclerosis Treatment Segment by Type
1.2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Comparison by Types (2014-2025)
1.2.2 COG-133
1.2.3 GZ-402668
1.2.4 Inebilizumab
1.2.5 VCE-0032
1.2.6 Others
1.3 Progressive Relapsing Multiple Sclerosis Treatment Segment by Application
1.3.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Comparison by Application (2014-2025)
1.3.1 Clinic
1.3.2 Hopital
1.3.3 Others
1.4 Progressive Relapsing Multiple Sclerosis Treatment Market by Region
1.4.1 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.4 China Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.5 Japan Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.7 India Progressive Relapsing Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.5 Global Progressive Relapsing Multiple Sclerosis Treatment Sales and Revenue (2014-2025)
1.5.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate (2014-2025)

2 Progressive Relapsing Multiple Sclerosis Treatment by Company, Region, Type and Application
2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Competition by Companies
2.1.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Company (2014-2019)
2.2 Global Progressive Relapsing Multiple Sclerosis Treatment Sales and Revenue by Region
2.2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Region (2014-2019)
2.3 Global Progressive Relapsing Multiple Sclerosis Treatment Sales and Revenue by Type
2.3.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2014-2019)
2.4 Global Progressive Relapsing Multiple Sclerosis Treatment Sales by Application

3 United States Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue and Price
3.1 United States Progressive Relapsing Multiple Sclerosis Treatment Sales and Revenue (2014-2019)
3.1.1 United States Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
3.1.2 United States Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States Progressive Relapsing Multiple Sclerosis Treatment Price Trend (2014-2019)
3.2 United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company
3.3 United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type
3.4 United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application

4 Europe Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue and Price
4.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Sales and Value (2014-2019)
4.1.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Price Trend (2014-2019)
4.2 Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company
4.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type
4.4 Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application

5 China Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue and Price
5.1 China Progressive Relapsing Multiple Sclerosis Treatment Sales and Revenue (2014-2019)
5.1.1 China Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
5.1.2 China Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
5.1.3 China Progressive Relapsing Multiple Sclerosis Treatment Price Trend (2014-2019)
5.2 China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company
5.3 China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type
5.4 China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application

6 Japan Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue and Price
6.1 Japan Progressive Relapsing Multiple Sclerosis Treatment Sales and Value (2014-2019)
6.1.1 Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan Progressive Relapsing Multiple Sclerosis Treatment Price Trend (2014-2019)
6.2 Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company
6.3 Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type
6.4 Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application

7 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue and Price
7.1 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Price Trend (2014-2019)
7.2 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company
7.3 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type
7.4 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application

8 India Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue and Price
8.1 India Progressive Relapsing Multiple Sclerosis Treatment Sales and Value (2014-2019)
8.1.1 India Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
8.1.2 India Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
8.1.3 India Progressive Relapsing Multiple Sclerosis Treatment Price Trend (2014-2019)
8.2 India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company
8.3 India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type
8.4 India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in Progressive Relapsing Multiple Sclerosis Treatment Business
9.1 Cognosci Inc
9.1.1 Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
9.1.2 Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
9.1.3 Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Genzyme Corp
9.2.1 Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
9.2.2 Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
9.2.3 Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 MedImmune LLC
9.3.1 MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
9.3.2 Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
9.3.3 MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 VivaCell Biotechnology Espana SL
9.4.1 VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
9.4.2 Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
9.4.3 VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
…

10 Progressive Relapsing Multiple Sclerosis Treatment Maufacturing Cost Analysis
10.1 Progressive Relapsing Multiple Sclerosis Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Progressive Relapsing Multiple Sclerosis Treatment
10.4 Progressive Relapsing Multiple Sclerosis Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Progressive Relapsing Multiple Sclerosis Treatment Distributors List
11.3 Progressive Relapsing Multiple Sclerosis Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Progressive Relapsing Multiple Sclerosis Treatment Market Forecast
13.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue and Price Forecast
13.1.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global Progressive Relapsing Multiple Sclerosis Treatment Price Trend Forecast (2019-2025)
13.2 Global Progressive Relapsing Multiple Sclerosis Treatment Forecast by Region
13.2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Progressive Relapsing Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Progressive Relapsing Multiple Sclerosis Treatment Forecast by Type
13.3.1 Global Progressive Relapsing Multiple Sclerosis Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global Progressive Relapsing Multiple Sclerosis Treatment Price Forecast by Type (2019-2025)
13.4 Global Progressive Relapsing Multiple Sclerosis Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Value (Revenue: Million US$)
Market Breakdown by Type: Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Revenue (Million US$)
Market Breakdown by Application: Progressive Relapsing Multiple Sclerosis Treatment Sales (Jan)
Figure Progressive Relapsing Multiple Sclerosis Treatment Product Picture
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) Growth Rate by Types (2014-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Types in 2018
Figure COG-133 Product Picture
Figure GZ-402668 Product Picture
Figure Inebilizumab Product Picture
Figure VCE-0032 Product Picture
Figure Others Product Picture
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Progressive Relapsing Multiple Sclerosis Treatment by Application in 2018
Figure Clinic Examples
Figure Hopital Examples
Figure Others Examples
Table Global Market Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) Growth Rate (2014-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Growth Rate (2014-2025)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) of Key Companies (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales by Company in 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Share by Company (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Share by Company in 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Company (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) by Company in 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Company (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Company in 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) Market Share by Region (2014-2019)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Share by Region (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Share by Region in 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Region (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Region In 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Share by Type (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate by Type in 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Share by Type (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Growth Rate by Type in 2018
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Share by Application (2014-2019)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table United States Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table United States Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table United States Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table Europe Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table Europe Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table Europe Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure China Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table China Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table China Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table China Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table Japan Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table Japan Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table Japan Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure India Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table India Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table India Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table India Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Table Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
Table Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
Table Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Main Business and Markets Served
Table Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
Table Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
Table Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Main Business and Markets Served
Table MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
Table MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
Table MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Main Business and Markets Served
Table VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Production Sites and Area Served
Table VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Specification and Application
Table VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Progressive Relapsing Multiple Sclerosis Treatment
Figure Manufacturing Process Analysis of Progressive Relapsing Multiple Sclerosis Treatment
Figure Progressive Relapsing Multiple Sclerosis Treatment Industrial Chain Analysis
Table Progressive Relapsing Multiple Sclerosis Treatment Distributors List
Table Progressive Relapsing Multiple Sclerosis Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) and Trend Forecast (2019-2025)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share Forecast by Regions in 2025
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure United States Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Revenue and Growth Rate Forecast (2019-2025)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) Forecast by Type (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share Forecast by Type (2019-2025)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share Forecast by Type (2019-2025)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の一次進行型多発性硬化症の治療市場2019
    Global Primary Progressive Multiple Sclerosis Treatment Sales Market Report 2019
    QYR9N3747 2019年6月13日 107Pages
    本調査レポートでは、一次進行型多発性硬化症の治療の世界市場について調査・分析し、一次進行型多発性硬化症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨー...
  • 世界の進行性多巣性白質脳症治療市場：市場規模・現状・予測
    Global Progressive Multifocal Leukoencephalopathy Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7888 2019年6月14日 94Pages
    当資料は、進行性多巣性白質脳症治療のグローバル市場について調査・分析したレポートで、種類別（抗レトロウイルス療法、抗ウイルス/抗JCV、その他の症状）、用途別（病院薬局、ドラッグストア、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...
  • 世界の多発性骨髄腫の治療市場：市場規模・現状・予測
    Global Multiple Myeloma Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7601 2019年6月14日 94Pages
    当資料は、多発性骨髄腫の治療のグローバル市場について調査・分析したレポートで、種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本...
  • 世界のマルチスピンドルヘッド市場2019
    Global Multiple Spindle Heads Sales Market Report 2019
    QYR9N2768 2019年6月10日 100Pages
    本調査レポートでは、マルチスピンドルヘッドの世界市場について調査・分析し、マルチスピンドルヘッドのメーカー別販売量、市場シェア分析、種類別販売分析（2スピンドルヘッド、3スピンドルヘッド、4スピンドルヘッド、その他）、用途別販売分析（建設、工業用、自動車、その他）、地域別販売分析（米国、ヨーロッパ、...
  • 世界の多周波バイオインピーダンスデバイス市場2019
    Global Multiple-frequency Bioimpedance Devicess Sales Market Report 2019
    QYR9N2769 2019年6月10日 118Pages
    本調査レポートでは、多周波バイオインピーダンスデバイスの世界市場について調査・分析し、多周波バイオインピーダンスデバイスのメーカー別販売量、市場シェア分析、種類別販売分析（有線バイオインピーダンスデバイス、ワイヤレスバイオインピーダンスデバイス）、用途別販売分析（病院、診療所、リハビリテーションセン...
  • 世界の複数通貨偽造紙幣探知機市場2019
    Global Multiple Currency Counterfeit Detector Sales Market Report 2019
    QYR9N2767 2019年6月10日 127Pages
    本調査レポートでは、複数通貨偽造紙幣探知機の世界市場について調査・分析し、複数通貨偽造紙幣探知機のメーカー別販売量、市場シェア分析、種類別販売分析（コンパクトタイプ、中型タイプ、大型タイプ）、用途別販売分析（小売、ホテル、銀行業、ギャンブル、輸送、その他）、地域別販売分析（米国、ヨーロッパ、中国、日...
  • 世界の人獣共通感染症の治療市場：市場規模・現状・予測
    Global Zoonotic Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8217 2019年6月14日 94Pages
    当資料は、人獣共通感染症の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）、用途別（病院、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のディンプル形成術の治療市場：市場規模・現状・予測
    Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7109 2019年6月14日 93Pages
    当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界の一次進行型多発性硬化症の治療市場2019世界の一次進行型多発性硬化症の治療市場2019 The global Primary Progressive Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Primary Progressive Multiple Sclerosis Treatment market status and forecast, categ…
  • 世界の進行性多巣性白質脳症治療市場：市場規模・現状・予測世界の進行性多巣性白質脳症治療市場：市場規模・現状・予測 Progressive multifocal leukoencephalopathy is a rare but debilitating and frequently fatal viral disease of the central nervous system, primarily affecting individuals with chronically and severely suppressed immune systems.Growing prevalence of HIV is expected to drive the growth of the progressive…
  • 世界の多発性骨髄腫の治療市場：市場規模・現状・予測世界の多発性骨髄腫の治療市場：市場規模・現状・予測 Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…
  • 世界のマルチスピンドルヘッド市場2019世界のマルチスピンドルヘッド市場2019 The global Multiple Spindle Heads market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Multiple Spindle Heads market status and forecast, categorizes the global Multiple Spindle Heads market size…
  • 世界の多周波バイオインピーダンスデバイス市場2019世界の多周波バイオインピーダンスデバイス市場2019 The global Multiple-frequency Bioimpedance Devicess market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report studies the global Multiple-frequency Bioimpedance Devicess market status and forecast, categorizes…